IMPORTANT: New DOT Drug Screen Requirements

December 8, 2017 | posted in: Uncategorized | by

The U.S. Department of Transportation has amended its regulations regarding drug screening. This is a substantial change that will take effect on January 1st, 2018. The standard 5-panel DOT drug test will be modified in the following ways:

  • The following substances will be added to the test panel: hydrocodone, hydromorphone, oxymorphone, and oxycodone. Common names for these include OxyContin, Percodan, Percocet, Vicodin, Lortab, Norco, Dilaudid, and Exalgo
  • Methylenedioxyamphetamine (MDA) will be added as an initial test analyte
  • Methylenedioxyethylamphetamine (MDEA) will be removed as a confirmatory test analyte

We are already prepared for this and the change will take place automatically starting January 1st, 2018. You do not need to take any additional action at this time.

Please note that we anticipate a price increase to go along with this, since the cost of the DOT test will rise with the addition of new substances. However, this will not be immediate and your current price for DOT testing will remain in place until further notice.

You can read the full text of the final rule on the DOT website.